These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11774474)

  • 1. Inefficient infection of soluble receptor-resistant mutants of murine coronavirus in cells expressing MHVR2 receptor.
    Matsuyama S; Taguchi F
    Adv Exp Med Biol; 2001; 494():233-6. PubMed ID: 11774474
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.
    Matsuyama S; Taguchi F
    Virology; 2000 Jul; 273(1):80-9. PubMed ID: 10891410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein.
    Holmes KV; Zelus BD; Schickli JH; Weiss SR
    Adv Exp Med Biol; 2001; 494():173-81. PubMed ID: 11774465
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurovirulence for mice of soluble receptor-resistant mutants of murine coronavirus JHMV.
    Matsuyama S; Watanabe R; Taguchi F
    Adv Exp Med Biol; 2001; 494():145-8. PubMed ID: 11774459
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation and characterization of murine coronavirus mutants resistant to neutralization by soluble receptors.
    Saeki K; Ohtsuka N; Taguchi F
    Adv Exp Med Biol; 1998; 440():11-6. PubMed ID: 9782259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor.
    Gallagher TM
    J Virol; 1997 Apr; 71(4):3129-37. PubMed ID: 9060676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro properties and pathogenesis of A59/MHV4 chimeric mouse hepatitis viruses.
    Tsai JC; Weiss SR
    Adv Exp Med Biol; 2001; 494():169-72. PubMed ID: 11774464
    [No Abstract]   [Full Text] [Related]  

  • 8. MHV neuropathogenesis: the study of chimeric S genes and mutations in the hypervariable region.
    Phillips JJ; Weiss SR
    Adv Exp Med Biol; 2001; 494():115-9. PubMed ID: 11774454
    [No Abstract]   [Full Text] [Related]  

  • 9. Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor.
    Matsuyama S; Taguchi F
    Virology; 2002 Mar; 295(1):160-71. PubMed ID: 12033774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the spike protein in murine coronavirus induced hepatitis: an in vivo study using targeted RNA recombination.
    Navas S; Seo SH; Chua MM; Das Sarma J; Hingley ST; Lavi E; Weiss SR
    Adv Exp Med Biol; 2001; 494():139-44. PubMed ID: 11774458
    [No Abstract]   [Full Text] [Related]  

  • 11. Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism.
    Navas S; Weiss SR
    J Virol; 2003 Apr; 77(8):4972-8. PubMed ID: 12663803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement in fusion activity of an epitope in the S2 subunit of murine coronavirus spike protein.
    Taguchi F; Shimazaki YK
    Adv Exp Med Biol; 2001; 494():213-8. PubMed ID: 11774471
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.
    Saeki K; Ohtsuka N; Taguchi F
    J Virol; 1997 Dec; 71(12):9024-31. PubMed ID: 9371559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the T1087N S gene mutation on MHV-A59 pathogenesis.
    Das Sarma J; Fu L; Lavi E
    Adv Exp Med Biol; 2001; 494():155-7. PubMed ID: 11774461
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein.
    Chua MM; Phillips JJ; Seo SH; Lavi E; Weiss SR
    Adv Exp Med Biol; 2001; 494():121-5. PubMed ID: 11774455
    [No Abstract]   [Full Text] [Related]  

  • 16. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.
    Navas S; Seo SH; Chua MM; Das Sarma J; Lavi E; Hingley ST; Weiss SR
    J Virol; 2001 Mar; 75(5):2452-7. PubMed ID: 11160748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amino acid insertions in the cysteine-rich domain of the MHV-A59 spike protein on cell fusion.
    Chang KW; Gombold JL
    Adv Exp Med Biol; 2001; 494():205-11. PubMed ID: 11774470
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the receptor-binding site of murine coronavirus spike protein.
    Suzuki H; Taguchi F
    J Virol; 1996 Apr; 70(4):2632-6. PubMed ID: 8642698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.
    Navas-Martin S; Hingley ST; Weiss SR
    J Virol; 2005 Jun; 79(12):7629-40. PubMed ID: 15919915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of proteolytic cleavage of the murine coronavirus MHV-2 spike protein for fusion activity.
    Yamada YK; Takimoto K; Yabe M; Taguchi F
    Adv Exp Med Biol; 1998; 440():89-93. PubMed ID: 9782269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.